Skip to content

Drug interactions

Bendamustine + Fostamatinib

Severity: Minor

Bendamustine and Fostamatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fostamatinib's active metabolite inhibits P-glycoprotein and could raise exposure to P-gp substrates. Bendamustine is not a well-established clinically sensitive P-gp substrate, so any increase in toxicity such as myelosuppression is theoretical.

What this interaction means in plain words

Bendamustine and Fostamatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bendamustine belongs to Oncology; Fostamatinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible inhibition of intestinal and cellular P-gp efflux by the fostamatinib metabolite tamatinib, which may modestly raise bendamustine exposure.

What to do

No dose change is generally needed; monitor blood counts as routinely done during bendamustine therapy and reassess if unexpected cytopenias occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bendamustine and Fostamatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Bendamustine with Fostamatinib?

MediHelp rates the interaction as minor. Bendamustine and Fostamatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fostamatinib's active metabolite inhibits P-glycoprotein and could raise exposure to P-gp substrates. Bendamustine is not a well-established clinically sensitive P-gp substrate, so any increase in toxicity such as myelosuppression is theoretical.

How serious is the interaction between Bendamustine and Fostamatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is generally needed; monitor blood counts as routinely done during bendamustine therapy and reassess if unexpected cytopenias occur.

What other medicines interact with Bendamustine?

MediHelp also lists interactions of Bendamustine with, for example, Axicabtagene ciloleucel, Brexucabtagene autoleucel, Chlorambucil. The full list is on the Bendamustine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in